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Peripheral nerve regeneration after severe traumatic nerve injury is a relevant clinical
problem. Several different strategies have been investigated to solve the problem
of bridging the nerve gap. Among these, the use of decellularized nerve grafts has
been proposed as an alternative to auto/isografts, which represent the current gold
standard in the treatment of severe nerve injury. This study reports the results of a
systematic review of the literature published between January 2007 and October 2017.
The aim was to quantitatively analyze the effectiveness of decellularized nerve grafts
in rat experimental models. The review included 33 studies in which eight different
decellularization protocols were described. The decellularized nerve grafts were reported
to be immunologically safe and able to support both functional and morphological
regeneration after nerve injury. Chemical protocols were found to be superior to physical
protocols. However, further research is needed to optimize preparation protocols,
including recellularization, improve their effectiveness, and substitute the current gold
standard, especially in the repair of long nerve defects.
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INTRODUCTION
Traumatic injury of peripheral nerves is of considerable clinical importance due to its high
incidence. The estimated incidence is upward of 300,000 cases per year in Europe (Kingham and
Terenghi, 2006) and more than one million per year worldwide (Daly et al., 2012). Peripheral
nerve lesions are five times more frequent than spinal cord lesions and results in decreased or
complete loss of sensitivity and/or motor activity. The ability of peripheral nerves to regenerate
has been recognized for more than a century; however, clinical and experimental evidence shows
that regeneration is often unsatisfactory, especially following severe injury (Navarro et al., 2007; Sun
et al., 2009; Pfister et al., 2011). For treating mild injury, direct suturing is the most common surgical
technique. For nerve substance loss, nerve autograft (transplantation of an autologous nerve)
Abbreviations: AG, autograft/isograft; AP, authors’ (in-house) protocol; AP-T, authors’ protocol using triton-X; AP-TPA,
authors’ protocol using triton-X and peracetic acid; AP-TS, authors’ protocol using triton-X and SDS; AP-W, authors’
protocol using Wallerian degeneration; CMAP, compound muscle action potential; CV, conduction velocity; FTP, freeze and
thaw protocol; HP, Hudson’s protocol; NP, Neubauer’s protocol; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate;
SFI, Sciatic Functional Index; SP, Sondell’s protocol.
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is currently the gold standard (Battiston et al., 2009) despite
its limitations (e.g., additional surgery, scarring, and donor-site
morbidity, limited source of donor nerves) (Hoben et al., 2018).
There is a strong need to find innovative therapies.
Recent research has focused on the use of biological and
synthetic conduits. Progress in materials sciences, with the
availability of new biomaterials and innovative manufacturing
procedures (Siemionow et al., 2013) has led to the development
of innovative artificial conduits. However, as the translation of
synthetic nerve grafts from bench to bedside is still limited,
biological tubulization remains the mainstay approach. Albert
(1885) first used a nerve graft from a donor (allograft) to
reconstruct a damaged nerve after resection of a sarcoma.
Although devoid of the drawbacks of autografts, allografts can
be rejected by the recipient body and therefore require systemic
immunosuppressive therapy. Advances in tissue engineering in
the last decade have led to the realization of decellularized
nerve allografts (Hundepool et al., 2017; Philips et al., 2018).
Unlike conventional allografts, they are cleaned of their antigenic
component yet retain their 3D structure which serves as scaffolds
for axonal growth. Decellularized nerve allografts could thus
represent a potentially ideal alternative.
The aim of this review was to quantitatively analyze the
relevant scientific literature for comparative assessment of the
effectiveness of nerve allografts in relation to decellularized grafts.
METHODS
The PubMed database was searched for articles published
in English between January 2007 and October 2017. The
search terms were “decellularization, decellularized, decellular,
acellularization, acellular, acellularized” combined with the
keyword “nerve.” The present study was focused on the
integration of decellularized nerve grafts and tissue repair
in rat models of peripheral nerve defects. Rat and mouse
models are often the first choice for nerve regeneration studies.
For this study we focused on the rat model because there
is a marked predominance of rat use in nerve regeneration
studies. Also, because rat nerves are larger and more resilient
than the corresponding mouse nerves, standardized functional
tests can be performed and the anatomy of rat nerves is
better known (Greene, 1935; Tos et al., 2008). A total of
185 studies were retrieved, of which 149 full-text articles were
excluded: 25 review articles; 30 articles because they concerned
decellularization of tissue or matrices other than nerves; 12
studies on engineered nerve tissue with different cell sources
unrelated to any decellularization protocol; 12 studies on the
repair of spinal cord injuries but not peripheral nerve lesions;
23 studies on the clinical use of commercial products for
which decellularization techniques are not described; 9 studies
described only in vitro approaches and investigations; 7 were
unrelated to nerve regeneration and/or integration; 8 involved
animal species other than rats; 26 lacked specific control groups,
such as the absence of autograft or pure decellularized nerve
graft implantation, making it impossible to verify the efficacy of
the decellularization protocols compared to the selected studies.
Ultimately, a total of 33 studies performed in rat models met our
inclusion criteria for this review of the literature (Figure 1 and
Table 1).
RESULTS AND DISCUSSION
Decellularization Protocols
Several studies described the attempt to repair severe nerve
damage by means of biologically derived scaffolds, such as
decellularized nerve grafts. There are three main decellularization
protocols for the creation of a functional graft: the one described
by Sondell et al. (1998) and Hudson et al. (2004), and the
combined Hudson protocol added with chondroitinase ABC by
Krekoski et al. (2001). SP was used in 33% of the studies (Jia
et al., 2012, 2017; Wang et al., 2012; Zhang et al., 2014; Zheng
et al., 2014; Zhou et al., 2014; Zhu and Weihua, 2014; Huang
et al., 2015; Garcia-Pérez et al., 2017; Zhu et al., 2015, 2017);
HP was used in 24% (Saheb-Al-Zamani et al., 2013; Gao et al.,
2014a; Hoben et al., 2015; Marquardt et al., 2015; Kim et al., 2016;
Tajdaran et al., 2016; Yan et al., 2016; Cai et al., 2017), and a
combined HP was used in 12% (Whitlock et al., 2009; Vasudevan
et al., 2014; Wood et al., 2014; Jiang et al., 2016). Other studies
(6%) used a FTP with or without the addition of chondroitinase
ABC as introduced by Krekoski et al. (2001; Godinho et al., 2013;
Wang H. et al., 2016). Moreover, others still (21%) developed an
in-house decellularization protocol and tested its efficacy against
autografts (Liu et al., 2011; Zhang and Lv, 2013; Wakimura et al.,
2015; Kusaba et al., 2016; Wang W. et al., 2016; Wang et al.,
2017b; Xiang et al., 2017). One study (3%) compared the efficacy
of Hudson’s, Sondell’s, and the FTP in the same experimental
setup (Nagao et al., 2011).
The most widely used protocol was developed by Sondell et al.
(1998) (SP), who demonstrated in vitro good removal of the
myelin sheath and cells, along with satisfying nerve regeneration
in the absence of inflammatory response in vivo. This method is
based on two sequential steps with a 3% Triton X-100 solution
followed by a 4% sodium deoxycholate solution, in which the
combination of a non-ionic surfactant with an anionic detergent
is considered efficient to chemically lyse cells.
Several years later, Hudson et al. (2004) proposed a milder
chemical treatment to better preserve the structure of the
extracellular matrix (ECM). HP requires several steps repeated
twice. In particular, an amphoteric detergent consisting of
125 mM sulfobetaine-10 (SB-10) solution is followed by
an anionic detergent solution of 0.14% Triton X-200 and
0.6 mM sulfobetaine-16 (SB-16). The use of detergents with
a demonstrated mild toxicity at low concentrations allowed
Hudson and co-workers to efficiently disrupt the cell membranes
while maintaining the ECM intact.
In order to eliminate chondroitin sulfate proteoglycans, which
are known to inhibit axonal growth and the growth-promoting
cues derived from the ECM components, Krekoski et al. (2001)
introduced a step of proteoglycan degradation by means of
the chondroitinase ABC enzyme, thus developing the so-called
NP. By adopting this improvement, many authors were able
to optimize their protocols by adding this degradation step
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FIGURE 1 | Research strategy. Flow chart of the selection process.
at the end of the decellularization process, especially after HP
and the FTP. The original NP started the process with thermal
decellularization, which is one of the most common methods to
produce biological acellular grafts. In this process, tissues usually
undergo three to five repeated freeze–thaw cycles.
In the various in-house protocols (Author’s protocol, AP),
three chemicals are employed to obtain nerve decellularization:
Triton-X100 or 200 (Liu et al., 2011; Zhang and Lv, 2013; Kim
et al., 2016; Wang et al., 2017b; Xiang et al., 2017) (AP-T; 50% of
all AP), its combination with SDS (Wakimura et al., 2015; Kusaba
et al., 2016; Wang H. et al., 2016) (AP-TS, 30% of AP) or with
peracetic acid (Cai et al., 2017) (AP-TPA, 10% of AP). Moreover,
Vasudevan et al. (2014) cultured explanted nerves in vitro with
normal culture media to initiate the Wallerian degeneration and
then in PBS to decellularize them and abruptly remove nutrient
supply (AP-W, 10% of AP). SDS is an anionic surfactant with
amphiphilic properties that lyses cells and denatures proteins.
Peracetic acid is a potent oxidizing agent used to sterilize collagen
tissues (Kemp, 1994; Gilbert et al., 2006). In decellularization,
it acts by enhancing tissue permeability, allowing detergent
penetration and subsequent cell colonization (Bottagisio et al.,
2016).
The first parameter in the choice of a decellularization
protocol is its duration. Duration is important for the time
needed to obtain the results, for the structural maintenance
of the biological scaffolds, and for the cost of the procedure.
In fact, the reduction of the entire process diminishes or
eventually avoids the need for sterilization techniques, such
as gamma irradiation, which has a controversial effect on
decellularized matrix integrity (Boriani et al., 2017). Another
issue is the use of numerous chemical detergents with reduced
incubation times during the decellularization protocol. Indeed,
the combination of different chemicals augments the deprivation
of ECM components (Alhamdani et al., 2010) but also permits
use of lower doses of detergents and shortens the incubation
time, thus facilitating the complete removal of detergents, which
results in a more suitable graft for cell repopulation (Rieder et al.,
2004; Serghei et al., 2010; Crapo et al., 2011) and makes the
procedure less time-consuming. In our analysis of the original
version of the protocols considered here, the FTP was found to
be the quickest and least laborious: it consists of three to five
brief freeze and thaw cycles and takes a few minutes to complete
without the need for chemical detergents and devoid of chemical
remains with toxic side effects (Serghei et al., 2010; Crapo et al.,
2011). All the other protocols take considerably longer: the HP
needs almost 69.5 h and the SP 86 h to complete. Besides its
shorter duration, the HP requires a lower percentage of chemical
detergents, making their elimination more easy. The NP entails
the chondroitinase ABC incubation step, which lasts 16 h, so the
total duration of decellularization before this step is increased by
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TABLE 1 | In vivo studies of nerve tissue decellularization and graft implantation.
Decellularization
protocol
Implantation
time (week)
Graft length
(mm)
Investigations Results Reference
SP; HP; FTP 52 15 Sciatic functional index AG = HP HP > FTP
and SP
Nagao et al., 2011
SP 8 10 Conduction velocity, latency period, wave
amplitude, muscle wet weight ratio, myelinated
fiber density, axon diameter, myelin sheath
thickness
AG > SP Jia et al., 2012
SP 2,12 20 Muscle wet weight and tension ratio,
myelinated fiber number, myelin sheath
thickness, Von Frey hair sensitivity test
AG > SP Wang et al., 2012
SP 1,2,4,8,12 15 Sciatic functional index, conduction velocity,
myelinated fiber density, myelinated fiber
number, myelin sheath thickness,
immunostaining
AG > SP Zhou et al., 2014
SP 8 10 Sciatic functional index, conduction velocity,
latency period, wave amplitude, muscle wet
weight ratio, myelinated fiber number, myelin
sheath thickness
AG > SP Zhang et al., 2014
SP 12 15 Sciatic functional index, conduction velocity,
muscle wet weight and tension ratio,
myelinated fiber density, axon diameter, myelin
sheath thickness, immunostaining, gene
expression (nerve growth factor, glial-derived
neurotrophic factor, growth-associated protein
43, neurofilament heavy)
AG > SP, AG = SP in
the first 6 weeks for
sciatic functional index.
Expression of all genes:
AG > SP
Zheng et al., 2014
SP 20 6 Latency period, wave amplitude, myelinated
fiber density, axon diameter, myelin sheath
thickness
SP = AG Zhu and Weihua,
2014
SP 1,2,4 15 Myelinated fiber density, axon diameter, myelin
sheath thickness Immunostaining Gene
expression (angiogenesis-related genes)
AG > SP Expression of
angiogenesis-related
genes: AG > SP
Zhu et al., 2015
SP 12 10 Conduction velocity Myelinated fiber density,
myelinated fiber number, axon diameter, myelin
sheath thickness Immunostaining
AG > SP, AG = SP
myelinated fiber
number Number of
Schwann cells:
AG > SP
Huang et al., 2015
SP 15 15 Sciatic functional index Immunostaining AG = SP Presence of
myelin in AG but not in
SP
Garcia-Pérez et al.,
2017
SP 8 10 Latency period, conduction velocity, wave
amplitude Muscle wet weight ratio Myelinated
fiber density, axon diameter, myelin sheath
thickness
AG > SP Presence of
laminin and myelin in
AG, in SP only laminin
Jia et al., 2017
SP 1,2,3,4 10 Immunostaining AG > SP Zhu et al., 2017
HP + NP 6,12,22 14,28 Sciatic functional index Muscle wet weight ratio
Myelinated fiber number, axon diameter
14-mm graft:
AG = HP + NP,
AG > HP + NP for
myelinated fiber
number at 6 weeks.
AG = HP + NP at
12 weeks 28-mm graft:
AG > HP + NP at 6
and 22 weeks
HP + NP resulted
non-immunogenic and
maintained laminin
structure
Whitlock et al.,
2009
HP 10,20 20,40,60 Muscle wet weight and tension ratio Myelinated
fiber number, axon diameter Immunostaining
Gene expression (senescence markers)
AG > HP Senescence:
AG < HP
Saheb-Al-Zamani
et al., 2013
(Continued)
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TABLE 1 | Continued
Decellularization
protocol
Implantation
time (week)
Graft length
(mm)
Investigations Results Reference
HP 6,12 10 Sciatic functional index Conduction velocity
Muscle wet weight ratio Axon diameter, myelin
sheath thickness
AG > HP Gao et al., 2014a
HP + NP; AP-W 12 35 Muscle wet weight and tension ratio Myelinated
fiber number, myelin sheath thickness
AG > HP + NP and AP-W,
HP + NP = AP-W
Vasudevan et al.,
2014
HP + NP 12 14 Myelinated fiber number, axon diameter, myelin
sheath thickness Retrograde nerve tracking
AG > HP + NP,
AG = HP + NP for
myelinated fiber number
Regenerating nerves:
AG = HP + NP,
allograft > xenograft
Wood et al., 2014
HP 10 20 Myelinated fiber density, myelinated fiber
number, axon diameter
AG > HP Hoben et al., 2015
HP 8 30 Muscle wet weight ratio Myelinated fiber
density, myelinated fiber number
AG > HP Marquardt et al.,
2015
HP 8 20 Muscle wet weight and tension ratio Myelinated
fiber number Gene expression (Glial-derived
neurotrophic factor)
AG > HP, AG = HP for
muscle tension ratio
Glial-derived neurotrophic
factor expression: AG > HP
Yan et al., 2016
HP 8 10 Myelinated fiber number, axon diameter, myelin
sheath thickness Retrograde nerve tracking
AG = HP, AG > SP for
myelinated fiber number
Regenerating neurons:
AG > HP
Tajdaran et al.,
2016
HP; HP + NP 12 15 Conduction velocity Muscle wet weight ratio
Myelinated fiber density, myelin sheath
thickness
AG > HP and HP + NP,
HP + NP > HP,
HP + NP = HP for myelin
sheath thickness
Jiang et al., 2016
HP; AP-T 12 15 Muscle wet weight ratio Myelinated fiber
density, myelin sheath thickness
AG > HP and AP-T,
AP-T > HP
Kim et al., 2016
HP; AP-TPA
Triton-X200 in
sulfobetaine 10 +
sulfobetaine 16 +
4% sodium
deoxycholate +
0.1% peracetic
acid
1,8 15 Muscle wet weight ratio Myelinated fiber
number, axon diameter, myelin sheath thickness
Thermosensitivity Immunological response
AG = AP-TPA, AG and
AP-TPA > HP,
AP-TPA = HP for
myelinated fiber number
In vivo host immune
response: AP-TPA < HP
Cai et al., 2017
NP 8,12 20 Sciatic functional index Muscle wet weight and
tension ratio Myelinated fiber number, axon
diameter, myelin sheath thickness ELISA
(collagen I and III)
AG = NP Collagen III
expression: AG = NP
Collagen I: AG < NP
Wang H. et al.,
2016
FTP (5 cycles) 10 10 Myelinated fiber number
Unmyelinated/myelinated axons ratio, area of
individual myelinated axon, number of axons in
unmyelinated bundle
AG = FTP Godinho et al.,
2013
AP-T 3 days,12 15 Sciatic functional index Conduction velocity,
latency period, wave amplitude Myelinated fiber
number, axon diameter, myelin sheath
thickness Immunostaining
AG > AP-T Liu et al., 2011
AP-T 12 15 Conduction velocity Muscle wet weight ratio
Immunostaining
AG > AP-T Presence of
acetyl
cholinesterase-positive
nerve fibers in motor
endplates in AG and AP-T
Zhang and Lv,
2013
AP-TS 4,24 10,15 Latency period, wave amplitude Myelinated
fiber density, myelin sheath thickness, axon
diameter Immunostaining Von Frey’s hair
sensitivity test, toe spread factor
AG = AP-TS Basal lamina
preserved in AG and AP-TS
Limited presence of
macrophage in both AG
and AP-TS
Wakimura et al.,
2015
(Continued)
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TABLE 1 | Continued
Decellularization
protocol
Implantation
time (week)
Graft length
(mm)
Investigations Results Reference
AP-TS 4,24 10,15 Latency period, wave amplitude Myelinated
fiber density, axon diameter, myelin sheath
thickness Immunostaining Von Frey’s hair
sensitivity test, toe spread factor
AG = AP-TS Basal
lamina preserved in AG
and AP-TS Limited
presence of
macrophage in both
AG and AP-TS
Wang W. et al.,
2016
AP-TS 25 15 Latency period, wave amplitude Myelinated
fiber density, axon diameter Von Frey’s hair
sensitivity test, toe spread factor
AG = AP-TS Basal
lamina preserved in AG
and AP-TS
Kusaba et al., 2016
AP-T 11 10 Muscle wet weight and tension ratio Axon
diameter, myelin sheath thickness
AG > AP-T, AG < AP-T
for axon diameter
Wang et al., 2017b
AP-T 2,12 15 Sciatic functional index Conduction velocity,
latency period Muscle wet weight ratio
Retrograde nerve tracking
AG > AP-T, AG = AP-T
for sciatic functional
index at 2 weeks
Cellularity and
regenerating fibers:
AG > AP-T
Xiang et al., 2017
AG, Autograft or isograft; HP, Hudson Protocol; NP, Neubauer Protocol; SP, Sondell Protocol; FTP, Freeze/Thaw Protocol; AP-T, Authors’ Protocol using Triton X; AP-TS,
Authors’ Protocol using Triton X + SDS; AP-TPA, Authors’ Protocol using Triton X + Peracetic Acid; AP-W, Authors’ Protocol using Wallerian degeneration.
16 h. In the group of AP, the AP-TPA was the quickest protocol,
taking 84.5 h, similar to the SP. The AP-T protocols varied in the
amount of time required for decellularization: from 70 h in the
protocol developed by Xiang et al. (2017) to 200 h in the protocol
by Wang et al. (2017b), with an average duration of 128 h. The
longest protocol was based on Wallerian degeneration developed
by Vasudevan et al. (2014) which required 2 weeks of culture in
complete culture medium and then another week of incubation
in PBS in order to deprive cells of nutrients.
Evaluation of Parameters to Measure
and Compare Nerve Decellularization
Protocols After in vivo Implantation
The efficacy of nerve regeneration with decellularized
nerve grafts was evaluated using quantitative analyses and
standardized parameters to compare study outcomes after
in vivo transplantation in rat models. We examined the SFI,
the von Frey hair sensitivity test, and the toe spread factor
which, altogether, indicate functional recovery after nerve
grafting. The SFI comprises values between -100 (complete loss
of functionality) to 0 (normal functionality). The von Frey hair
sensitivity test entails stimulation of the animal’s paw by means
of increasingly stiff nylon monofilaments; paw withdrawal and
flinch are considered positive responses and the test results
are presented as a correlation between stimulus intensity and
type of response (Chaplan et al., 1994). The toe spread factor is
calculated on the basis of the distance from the first to the fifth
toe (Geuna et al., 2009).
Among the various electrophysiological tests that evaluate
ex vivo recovery of the graft‘s electrical functionality after
implantation, conduction velocity (CV, m/s) through the graft
and compound muscle action potential (CMAP, mV), and two
features derived from CMAP, i.e., latency period (µsec) and wave
amplitude (mV), were analyzed. CMAP records the summation
of all muscle fiber action potentials derived from the activation
of a group of motor neurons within a nerve bundle by means of a
brief electrical stimulation. The latency period is the time between
the application of an electrical stimulus to a nerve and muscle
contraction. The wave amplitude represents the maximum value
measured from baseline in the CMAP-resulting curve.
To assess muscle atrophy and functional recovery of the
muscles most commonly analyzed (gastrocnemius, triceps surae,
extensor digitorum, and tibialis anterior), muscle wet weight and
maximum contraction tension were considered. Both parameters
were analyzed by the studies ex vivo and mainly expressed as
the ratio between the operated and the uninjured side. Moreover,
since functional recovery is based on restoration of physiological
neuronal morphology (Geuna et al., 2009), histomorphometric
parameters were examined, including myelinated axon number,
density (number of fibers/mm2), total fiber number, axon
diameter (µm), and myelin sheath thickness (µm).
Morphological and Functional
Comparison of Autografts and Sham
Control of Nerve Gap Reconstruction in
Rat Models
For a quantitative assessment of the functional and
morphological recovery of the nerve graft, all manuscripts
published in the literature and reporting numerical values for
nerve recovery in terms of functionality and morphology over
time were analyzed. Specifically, three different time points
were considered: 2–5, 6–9, and 10–15 weeks after implantation.
Comparable results from week 2 after graft implantation –
the time in which nerve regeneration begins - until week 15
after surgery were evaluated. After surgical grafting, 3–6 weeks
are necessary for Schwann cells and macrophages to arrive
at the injury site and clear it of cellular and myelin debris
(Geuna et al., 2009). The Schwann cells then start to proliferate,
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organizing themselves in columns to permit the association of
the regenerating axons. The choice of 15 weeks as the last time
point was based on the study by Waitayawinyu et al. (2007),
who reported that analyzing the outcomes of nerve recovery
beyond 15 weeks may lead to misleading interpretations because
differences between the experimental groups might be lost, also
given the high regenerative capacity of the rodent model.
Most studies (Liu et al., 2011; Wang et al., 2012; Zhang and
Lv, 2013; Gao et al., 2014a; Vasudevan et al., 2014; Wood et al.,
2014; Zheng et al., 2014; Zhou et al., 2014; Huang et al., 2015;
Jiang et al., 2016; Kim et al., 2016; Wang H. et al., 2016; Xiang
et al., 2017) (39% of the studies included) set week 12 as the last
endpoint and a few went beyond the 15th week. For instance,
Zhou et al. (2014) and Saheb-Al-Zamani et al. (2013) evaluated
the regenerative process until week 20, Whitlock et al. (2009)
until week 22, Wakimura et al. (2015), Kusaba et al. (2016), and
Wang W. et al. (2016) until week 24, and Nagao et al. (2011) until
week 52.
As autografting represents the gold standard procedure for
peripheral nerve reconstruction, we first analyzed its outcomes
and then compared them with those obtained from sham
procedures on healthy nerves. Only five studies included a sham
control (Nagao et al., 2011; Tajdaran et al., 2016; Wang H.
et al., 2016; Wang et al., 2017b; Garcia-Pérez et al., 2017), in
which a slight decrease in nerve functionality after sham surgery
(sham control) was found compared to that of the native nerves.
This small number of studies could constitute a limitation of
the present literature review and preclude comparison of the
parameters analyzed. Taking into account that evaluation based
on the SFI could vary widely depending on artifacts and operator
ability (Varejao et al., 2001; Nichols et al., 2005; Monte-Raso et al.,
2008; Fricker et al., 2016), the mean SFI of the sham controls
was −8.16 at week 15 (Nagao et al., 2011; Wang H. et al., 2016;
Wang et al., 2017a; Garcia-Pérez et al., 2017). Only one study
reported a SFI of −2, which approached the normal value at
52 weeks after surgery (Nagao et al., 2011). The SFI of autografts
was expected to be lower than the sham surgery. The average SFI
values were, in fact, significantly lower for the autografts than
the sham controls at all time points. These data indicate that
also sham surgery affects nerve functionality, albeit to a lesser
extent. Differently, although autografting compromised nerve
functionality initially, there was a predictable improvement in the
SFI over time, indicating that nerve regeneration and recovery
processes had begun.
The electrophysiological parameters (CV, WA, and LP)
reported in Figure 2 were compared among studies, obtaining
data for the sham controls and AG 2–5 weeks from one study
(Wang H. et al., 2016), for AG 6–9 weeks from four studies (Jia
et al., 2012; Zhang et al., 2014; Wang H. et al., 2016; Jia et al.,
2017), and for AG 10–15 weeks from six studies (Liu et al., 2011;
Zhang and Lv, 2013; Zheng et al., 2014; Huang et al., 2015; Jiang
et al., 2015; Wang H. et al., 2016). The low amount of recorded
data did not permit to statistically analyze the differences in the
results. However, the trend of the electrophysiological parameters
(Figure 2) showed higher CV and wave amplitude values for
the sham control, while the latency period in the autografts was
longer during the first 5 weeks after surgery and almost the same
FIGURE 2 | Average values of electrophysiological parameters indicating the
electrical functionality of nerves. The Conduction Velocity (CV; m/s), Wave
Amplitude (WA; mV) and Latency Period (LP; ms) are compared between
sham control and autografts (AG) at different time points. Data are reported as
mean ± SD.
for the two groups at the later time points. At 6–9 weeks, this
parameter was even lower for the autografts, probably because
only one study reported data for the sham control (Wang H. et al.,
2016). The three parameters showed improvement over time,
with an increase in CV and wave amplitude at the last time point,
reaching half that of the sham control values. Otherwise, the
latency period shortened over time, similar to the sham control
value.
Muscle functionality, reported as the muscle wet weight and
tension ratio, was greater in the sham control compared to
autografts at all time points. The average muscle wet weight ratio
in the sham control was 82% of that of the native limb (Wang
H. et al., 2016), while the ratio obtained with the autografts was
increased over time, from a mean of 46.3–51.6% from weeks 6–9
to 10–15, though none of the studies analyzed this parameter
during the first 5 weeks (Whitlock et al., 2009; Liu et al., 2011;
Jia et al., 2012, 2017; Wang et al., 2012, 2017a; Zhang and Lv,
2013; Vasudevan et al., 2014; Zheng et al., 2014; Marquardt et al.,
2015; Jiang et al., 2016; Kim et al., 2016; Wang H. et al., 2016;
Yan et al., 2016; Cai et al., 2017). The average muscle tension was
75% for the sham control and 54.7% for the autografts at the last
time point; no analyses were performed at earlier time points.
These results demonstrated that the autografts supported and
strengthened reinnervation along the graft over time, resulting
in a decrease in muscle atrophy and reinforcement of the tension
that the muscles were able to elicit.
In the case of histomorphometric analyses, several authors
reported evaluable data to be analyzed through non-parametric
statistical tests, as reported in Figure 3. Indeed, for the sham
controls, five authors reported quantitative parameters (Jia et al.,
2012, 2017; Zhang et al., 2014; Wang H. et al., 2016; Wang et al.,
2017b). For AG at 6–9 weeks, seven records indicated values for
myelin and axon morphology (Whitlock et al., 2009; Jia et al.,
2012; Zhang et al., 2014; Marquardt et al., 2015; Tajdaran et al.,
2016; Cai et al., 2017; Jia et al., 2017), as well as, fourteen records
detailed values for AG at 10–15 weeks (Whitlock et al., 2009;
Liu et al., 2011; Wang et al., 2012, 2017b; Godinho et al., 2013;
Vasudevan et al., 2014; Wood et al., 2014; Zheng et al., 2014;
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FIGURE 3 | Quantitative analysis of the neuronal morphology based on different parameters emerging from the histomorphometric evaluations. The myelinated fiber
density (number of axons per mm2), myelinated fiber number, axon diameter (µm) and myelin sheath thickness (µm) are compared between sham control and
autografts (AG) at different time points. One way ANOVA for nonparametric data and Dunns’ post hoc correction was performed. Data are reported as mean ± SD,
∗∗p < 0.01.
Zhou et al., 2014; Hoben et al., 2015; Huang et al., 2015; Jiang
et al., 2015; Kim et al., 2016; Wang H. et al., 2016).
As expected, myelinated fiber density and number were
lower in the sham control than with the autograft at 6–9
and 10–15 weeks (Figure 3). The axon diameter in the sham
controls showed a normal opposite trend, with a significant
difference compared to the autografts at 10–15 weeks (p < 0.01).
Unexpectedly, myelin sheath thickness was comparable between
the sham controls and autografts and over time was decreased for
the autografts. These data are far higher than normal estimated
for a regenerating nerve, in which myelin sheath thickness
is expected to be lower than in sham controls and directly
proportional to the regenerating axon diameter, especially during
the first weeks of regeneration.
There was a fluctuating trend for myelinated fiber density
in the autografts owing to the study by Zhou et al. (2014)
who reported a value of 53876 at weeks 2–5 (data not
shown). Moreover, the myelinated fiber density in the autografts
continued to increase, reaching 29000 myelinated fibers/mm2
at 24 weeks, as reported by Wakimura et al. (2015) and Wang
W. et al. (2016). These authors also reported an average myelin
sheath thickness of 1 µm at 24 weeks after surgery (Wakimura
et al., 2015; Wang W. et al., 2016). In addition, the axon diameter
increased, reaching 5.6 µm (Wakimura et al., 2015; Kusaba et al.,
2016; Wang W. et al., 2016). The data reported in Figure 3 do not
include the results reported by Godinho et al. (2013) because they
seem to differ greatly (23000 myelinated fiber number) from the
physiological parameters of a healthy nerve.
Interestingly, Godinho et al. (2013) evaluated three more
parameters that could be useful for gaining a broader perspective
on nerve function recovery at 8 weeks after surgery. The first
parameter was the unmyelinated and myelinated axon ratio,
which was 6 in the sham control and 3 in the autograft.
The second was the average number of axons in unmyelinated
bundles, which was 3.5 in both groups. Moreover, in the same
study, the sectional area of the myelinated axons was greater in
the sham control than in the autograft group (9.5 vs. 3.6 µm2).
Overall, most of the studies reported consistent and
comparable results for SFI, muscle wet weight ratio, and wave
amplitude. Only a few reported values that substantially differed
from the mean. In the autograft group, Wang et al. (2017b)
reported a SFI markedly lower than average at all three time
points, with a value of −48 at weeks 2–5, −45 at weeks 6–9, and
−40 at weeks 10–15. Zhang et al. (2014) reported a much higher
SFI and muscle wet weight ratio, with an increase from –32.3
after 2 weeks to –18.7 after 8 weeks and a muscle weight ratio of
89.5% at 8 weeks after surgery. Also, Xiang et al. (2017) reported
a SFI value higher (−17) compared to the autograft average at
12 weeks. Liu et al. (2011) found a wave amplitude of 29.5 mV
at 12 weeks after autografting, which was twice the mean value
obtained for the sham control.
As expected, the overall values for the autografts were lower
than the sham controls. In the majority of the parameters,
there was a positive trend for the autografts over time,
indicating a progressive recovery in nerve functionality and
morphology. This recovery is due to the autografts providing
viable Schwann cells and neurotrophic factors that support nerve
axon regeneration (Flores et al., 2000; Siemionow and Brzezicki,
2009). Autografts are, in fact, effective and employed in the
treatment of severe nerve injury in clinical practice (Rinker and
Vyas, 2014). Based on this premise, the outcomes with autografts
were compared with the results obtained with the different
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 November 2018 | Volume 12 | Article 427
fncel-12-00427 November 19, 2018 Time: 12:12 # 9
Lovati et al. Decellularized Nerve Grafts
decellularization protocols and were considered as benchmark
values for evaluating the recovery of graft functionality and
morphology.
Morphological and Functional Outcomes
of Nerve Grafts Obtained With
Decellularization Protocols
In order to evaluate the functional and morphological efficacy of
decellularized nerve grafts at the three time points (2–5, 6–9, and
10–15 weeks after implantation), these parameters were analyzed
and compared with respect to the decellularization protocols and
to autografts or isografts used as the gold standard.
Also, the implanted graft length was considered. The success
of regeneration has been shown to be proportional to the
extent of the interstump zone and of the advancing sprouting
cell protrusions. Nerve regeneration takes place through the
extension of Schwann cell protrusions rather than axonal growth;
Schwann cells guide and support the regenerating axons and
regulate the rate of the recovery process (Son and Thompson,
1995). Lundborg et al. (1982) experimentally fixed at 10 mm
the length beyond which the nerve injury is considered a
critical defect in the rat model. This limit was corroborated
by Saheb-Al-Zamani et al. (2013) who found it difficult to
regenerate with the use of decellularized grafts longer than
20 mm and reported no regeneration in grafts in 60 mm
long. Therefore, graft length is a crucial feature, as are its
functional and morphological recovery properties, for developing
a suitable alternative to autografts. Moreover, as stated by Hare
et al. (1992) and demonstrated by Whitlock et al. (2009),
the use of a very long nerve graft (28 mm) could produce
misleading results in the evaluation of nerve functionality due
to the poor reinnervation process along the distal edges of the
grafts.
In the studies that used the classic decellularization protocols
(SP, HP, NP, and FTP), the majority (75.8%) used grafts ranging
in length from 10 to 15 mm (Whitlock et al., 2009; Liu et al.,
2011; Nagao et al., 2011; Jia et al., 2012, 2017; Godinho et al.,
2013; Zhang and Lv, 2013; Gao et al., 2014a; Wood et al.,
2014; Zhang et al., 2014; Zheng et al., 2014; Zhou et al., 2014;
Huang et al., 2015; Wakimura et al., 2015; Zhu et al., 2015;
Jiang et al., 2016; Kim et al., 2016; Kusaba et al., 2016; Tajdaran
et al., 2016; Wang W. et al., 2016; Wang et al., 2017b; Cai
et al., 2017; Garcia-Pérez et al., 2017; Xiang et al., 2017). Among
the others, only Zhu and Weihua (2014) used a shorter graft
(6 mm), while others still used longer grafts: a 20-mm graft in
five studies (Wang et al., 2012; Saheb-Al-Zamani et al., 2013;
Hoben et al., 2015; Yan et al., 2016; Wang H. et al., 2016); a
30-mm graft in two (Whitlock et al., 2009; Marquardt et al.,
2015); a 35–40 mm graft in two (Saheb-Al-Zamani et al., 2013;
Vasudevan et al., 2014), and a 60- mm graft in one study (Saheb-
Al-Zamani et al., 2013). The mean graft length used with the
SP was 12.6 mm, 16.7 mm with the HP, 21 mm with the NP,
and 12.5 mm with the FTP. Regarding the various in-house
protocols, the average graft length was 14.3 mm (range, from
10 to 15 mm), except for the 35-mm-long graft developed by
Vasudevan et al. (2014). The average length of the AP-T grafts
was 14 mm and that of the AP-TS and AP-TPA grafts was 15 mm.
In general, the average length of the autografts and isografts was
14.8 mm.
Sciatic Functional Index
Like the autografts, all the decellularized grafts, except for those
produced using the NP, showed an improvement in the SFI
(Table 2). In particular, the results of the grafts produced using
the SP seemed to be closer to those obtained with the autografts.
It has to be taken into account, however, that the average SP
graft length was 4 mm shorter than that of the autografts or the
HP grafts and 9 mm shorter than the NP grafts. This difference
could influence the SFI, although no studies examined whether
length difference had an impact on the SFI. Zhang et al. (2014)
reported a value of −33.39 for SP grafts at 8 weeks after surgery,
a value much higher than the SP or the autograft average. Only
two studies calculated the SFI of the NP grafts (Whitlock et al.,
2009; Wang H. et al., 2016a). Wang H. et al. (2016) reported
higher positive values than Whitlock et al. (2009) which could
explain the opposite trend observed in this protocol. Only Nagao
et al. (2011) calculated the SFI in HP and FTP grafts, while
only Liu et al. (2011) evaluated it in AP-T grafts. This lack of
relevant data precluded analysis of this parameter. Therefore,
our analysis focused on the study by Nagao et al. (2011) who
evaluated and compared the SFI for the SP, HP, and FTP grafts
in the same experimental procedure. They found that the grafts
reached a plateau in the recovery of SFI at 12 weeks, and that from
week 12 until week 52 the SFI for the HP grafts was statistically
superior compared to the SP and FTP grafts. In brief, a more rapid
recovery during the first weeks after surgery was noted for the HP
grafts, which then maintained a higher SFI over time.
Extensively employed in nerve injury and recovery studies,
this parameter is generally considered to be highly accurate and
reliable in describing sciatic nerve function (Varejao et al., 2001;
Nichols et al., 2005). Nonetheless, SFI has certain disadvantages:
frequent footprint artifacts and distortions produced by smearing
of the ink when applied to the rats’ paws (Fricker et al., 2016);
the footprint key points have to be adequately recognized and
analyzed, which are operator dependent (Monte-Raso et al.,
2008). For these reasons, together with the lack of data, this
parameter was insufficient to describe functional recovery, but it
was used to complete the evaluation of functional restoration in
association with other parameters.
Electrophysiology
In our analysis of the electrophysiological features of
decellularized nerve grafts, sufficient data for a comparison
were available only for CV at 10–15 weeks (Table 3).
Electrophysiological measurement allows for a meaningful
evaluation of the effective re-innervation of the graft over time.
For instance, latency period and CV are correlated with the
myelination rate and the size of the regenerating axons (Geuna
et al., 2009). The CV can be subject to high variability during
recording, however (Geuna et al., 2009). Nonetheless, it is a
reliable factor for the evaluation of nerve regeneration (Booth
and Gollnick, 1983). The CV in nerve grafts obtained with NP,
HP, and AP was nearly half that of the SP grafts, which showed
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CV values slightly below those of the autografts. CV in the HP
and NP grafts was measured only in one study (Jiang et al., 2016).
The wave amplitude is correlated with the number and size of
effectively regenerated axons, in which electrical impulses can be
propagated. Also, CV is influenced by the graft distance (Geuna
et al., 2009). The best results were obtained with the AP-T grafts,
with higher values than those of the autografts. The amplitude of
the SP grafts was half that measured for the autografts, although
evaluated at the previous time point (data not shown). Given
the longer average length of the AP-T grafts, this outcome was
remarkable, notwithstanding its being calculated only by Liu
et al. (2011). In contrast, the latency period was shorter in the
SP than the AP-T grafts, indicating greater fiber maturation in
the SP than in the AP-T grafts (Wang W. et al., 2016) (data not
shown).
All the studies on AP-TS grafts evaluated the wave amplitude
and latency period at 25 weeks after surgery. The results were
expressed in percentage (43.2 and 46.9%, respectively) with
respect to the contralateral non-operated limb, precluding their
comparison with the other groups (Wakimura et al., 2015;
Kusaba et al., 2016; Wang W. et al., 2016).
Due to the variability in the CV recordings and the
absence of data for wave amplitude and latency period, the
electrophysiological parameters need to be correlated with other
functional and morphological data in order to evaluate the whole
regeneration process.
Muscle Functionality
Evaluation of muscle functionality is the key to assessment of
the progress of nerve regeneration. The muscle wet weight ratio
is related to muscle atrophy: without physiological innervations,
muscles would undergo atrophy and loss of functionality and
lose weight. Therefore, an increase in muscle weight and tension
reflects the effective reinnervation of a graft able to conduct
and deliver electrical stimuli to the target effector muscle (Zhao
et al., 2014; Wang et al., 2015). The peripheral nervous system
is capable of a certain degree of self-regeneration (Cerri et al.,
2014). But when nerve continuity is interrupted, and particularly
when the gap defect is large, complete reinnervation will be
difficult. For this reason, we considered the muscle functionality
parameter as being highly relevant for predicting effective
functional recovery. Restoration of muscle function implies that
the regenerating nerve fibers have effectively crossed the graft
and reached the target muscle. In the present analysis, the best
result was obtained with AP-TPA grafts, which showed the best
muscle mass recovery similar to that of autografts (Table 4).
This represents a remarkable result because it was evaluated at
8 weeks after surgery with a 15-mm-long graft (Cai et al., 2017).
Unfortunately, no data on muscle tension were reported for AP-
TPA grafts. Among the other protocols, the HP grafts came the
closest to the autografts at the last time point, with increasing
improvement over time and good recovery from muscle atrophy.
The NP grafts started at a value similar to the HP grafts at weeks
6–9 but the rate of improvement fell behind that of the HP grafts
over the following weeks, probably due to the higher average
length of the grafts. In contrast, no increase was observed for
the SP grafts. Moreover, Zhu and Weihua (2014) found some
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motoneuron endplate activity in the SP grafts also on the operated
side, but Zheng et al. (2014) reported that these motor endplates
were scarce and characterized by serious atrophy. Vasudevan et al.
(2014) calculated the muscle wet weight ratio for AP-W grafts
and reported the lowest outcomes of all the decellularization
protocols.
The muscle tension ratio was evaluated only for the SP, NP, and
AP-T grafts at weeks 10–15 (Table 5). It reflected the same trend
of the previous parameter, in which the muscle tension ratio for
the AP-T grafts was slightly higher than that of the NP grafts,
which was greater than that of the SP grafts, albeit to a lesser
extent. This parameter was calculated only by one author for both
NP (Wang H. et al., 2016) and AP-T grafts (Wang et al., 2017b).
Further evidence of recovery of muscle functionality
was presented by Zhang and Lv (2013) and Zhu and
Weihua (2014) who demonstrated, in SP and AP-T grafts,
respectively, the presence of fibers positive to acetylcholinesterase
immunostaining in some motoneuron endplates.
Morphology
Quantitative histomorphology is an essential method to
investigate nerve regeneration, as numerous morphological
parameters can be associated with functional outcomes (Geuna
et al., 2004; Vleggeert-Lankamp, 2007). Table 6 presents the
morphological data, in which only values at 10–15 weeks are
included since the results at this time point were richer. AP-TPA
is an exception because it had better and promising outcomes
than the other decellularization protocols. It has been included
in the table even if it was evaluated at 6–9 weeks.
Myelinated fiber density
The number of myelinated neurons in a regenerating nerve
reflects the rate of functional recovery (Geuna et al., 2009).
Regenerating nerves are initially characterized by a shortage
of myelin, but, thanks to the action of Schwann cells, the
fibers will be surrounded in a myelin layer (Flores et al.,
2000). Myelinated fiber density is also related to a nerve’s
electrophysiological characteristics and provides a meaningful
measure of the recovery process (Russell et al., 1996).
The highest myelinated fiber density, comparable to autograft
values, was measured in FTP grafts, and it was evaluated only
in one study (Godinho et al., 2013). Comparable results were
obtained with SP and HP grafts, in which the fiber density was
almost half that of the autografts. Some studies published very
variable values for myelinated fiber density. Zhu et al. (2015)
and Zhou et al. (2014) reported unexpectedly higher density
values for SP grafts with respect to autografts at 2–5 (48231) and
10–15 (40523) weeks, while Zhu and Weihua (2014) reported a
lower density of 2090 at week 20. The average density of the NP
grafts, calculated only at 10–15 weeks, was the lowest among the
decellularized grafts.
Among the grafts produced with an in-house protocol, the AP-
T grafts had an intermediate value between the SP/HP and the
NP grafts. For the same group (AP-T), Liu et al. (2011) reported
only 0.03 myelinated fibers per mm2 at week 12, considerably
lower than those reported by other studies. The myelinated fiber
density of AP-W grafts, reported only by Vasudevan et al. (2014),
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was out of range since it was almost twice that of the autografts.
However, the same study reported a density value out of range
also for the NP grafts (75000), which was greater than that of the
AP-W grafts. The AP-TS grafts had a higher density (17050) than
the HP grafts, though this difference might have resulted from
the late time point considered in these studies (Wakimura et al.,
2015; Kusaba et al., 2016; Wang W. et al., 2016).
Myelinated fiber number
Since some studies evaluated either myelinated fiber density or
myelinated fiber number, we examined both these parameters
even if their functional significance is identical. Unlike
myelinated fiber density, myelinated fiber number was similar in
NP grafts and autografts. As seen for other parameters, already
at weeks 6–9, the fiber number in the AP-TPA grafts was higher
than in those produced with other decellularization protocols
and was only slightly lower than the autografts (5743 at week
6–9). The grafts with the lowest number of myelinated fibers
were produced with AP-T (Kim et al., 2016) and SP (Huang et al.,
2015), though only one study evaluated both types of grafts.
Axon diameter
The average axon diameter in a regenerating nerve is an
important parameter; it is the determining factor that influences
CV and defines the capacity of nerves to transmit electrical
stimuli (Hoffman, 1995; Assaf et al., 2008). During the
regeneration phase in the first weeks after injury, the axon
diameter increases. Evaluation of this parameter during the very
early phases may be challenging, however, because it is difficult to
discern between small successfully regenerated fibers from small
atrophic or dying fibers (Ikeda and Oka, 2012). For this reason,
we compared the results measured at the last time point. Axon
diameter in AP-TS grafts was the largest (5.4 µm) since it was
evaluated at week 25. Once again, AP-TPA had the best outcome
among the other protocols, although evaluated only at 8 weeks
after surgery. This value was even slightly greater than that for
autografts measured at the same time point (3.8 µm), meaning
that this graft type probably also had a high CV, which was not
experimentally measured, however. The NP grafts had the largest
diameter, reflecting the outcome derived from CV recording. HP
grafts were evaluated only by one study (Hoben et al., 2015),
which found an intermediate value, confirming the graft’s average
velocity in the conduction of electrical stimuli. The SP grafts were
re-innervated by axons with a diameter among the lowest, higher
only than that of the AP-T grafts. In addition, Zhu and Weihua
(2014) demonstrated that axon diameter was increased slightly
in the SP grafts, reaching 2.5 µm at week 20. A discrepancy was
noted in the comparison with the CV recorded for SP grafts: while
these grafts had the fastest CV, their axon diameter was among the
lowest. This cannot be elucidated by the reported data, since the
parameters were evaluated by different studies and were nearly
comparable, albeit with low variance. Finally, in line with CV
outcomes, the axons in the AP-T grafts had the smallest diameter.
Myelin sheath thickness
Myelin sheath thickness has been shown to correlate with
the functional recovery of regenerating nerves (Kanaya et al.,
1996). During the early period after injury, the axon diameter
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decreases and then later increases over time (Sanders, 1948).
The decrease in axon diameter is associated with a mild increase
in myelin sheath thickness, maintaining the size of the entire
fiber steady. The axons then start to increase their diameter,
causing the surrounding myelin sheath to decrease in thickness
(Sanders, 1948). The correlation between these two parameters is
useful for interpreting the results. For instance, in the AP-TPA
grafts, despite measurement at an earlier time point, myelin
sheath thickness and axon diameter were nearly comparable
to those of the autografts, meaning that these two types of
grafts were probably almost at the same regeneration phase.
This comparison was not possible with NP grafts, as myelin
sheath thickness was evaluated only at the last time point. Its low
value, together with the increased axon diameter, suggested that
the grafts were further along in the regeneration process than
the HP grafts. In fact, axon diameter was smaller, while myelin
sheath thickness remained substantially unchanged, indicating
that the HP grafts were probably still in an intermediate phase
of regeneration. Kim et al. (2016) reported a myelin sheath
thickness of 4 µm in HP grafts at 12 weeks after the graft
procedure, which was much higher and out of the range, even
when compared with autografts. Differently, a slight increase in
axon diameter and a slight decrease in myelin sheath thickness
was observed in SP grafts, suggesting that they were probably at
the beginning of the second phase of regeneration. The AP-TS
grafts were re-innervated by large axons (5.4 µm in diameter)
and had a lower myelin sheath thickness (0.8 µm), indicating
good progress in the regeneration process, as expected, given
the time point at which they were evaluated. Conversely, the
myelin sheath was thickest in the AP-T grafts, in which the
axon diameter was among the smallest. In this case, the myelin
sheath thickness reported for this graft type appeared to be
outside the expected physiological range, as mentioned in Section
“Morphological and Functional Comparison of Autografts and
Sham Control of Nerve Gap Reconstruction in Rat Models.”
Unfortunately, some of the studies (Liu et al., 2011; Kim
et al., 2016) reported unforeseen and off-the-scale values due
to possible methodological sampling errors or, more commonly,
insufficient methodological information to obtain significant
results, as demonstrated elsewhere (Geuna et al., 2004; Geuna and
Herrera-Rincon, 2015).
Other histomorphological parameters
The unmyelinated/myelinated axon ratio, the number of axons
in the unmyelinated bundle, and the sectional area of single
myelinated axons were evaluated by Godinho et al. (2013) in
FTP grafts at weeks 10–15. The unmyelinated/myelinated axon
ratio was also evaluated in AP-TS grafts (Wang W. et al., 2016).
Unmyelinated axons are physiologically present in the peripheral
nervous system and can result locally abundant, accounting for
about 75% of axons in the cutaneous nerves of mammals (Geuna
et al., 2009). They are usually small; given the lack of a myelin
sheath, they do not permit saltatory conduction, resulting in a
lower CV. Both FTP (with an unmyelinated/myelinated axon
ratio of 4) and especially AP-TS grafts (with a ratio of 5.3) seemed
to be re-innervated by a higher number of unmyelinated neurons
compared with autografts, in which the ratio was 3.5. This implies
that the CV was slower in these grafts, though evidence for this
parameter was not directly evaluated.
Godinho et al. (2013) observed a difference in axon sectional
area between FTP grafts and autografts (2.1 µm2 vs. 3.6 µm2),
supporting the hypothesis that CV in FTP grafts is slower. In
addition, the two parameters correlating with functional recovery
were evaluated in AP-TS grafts (Wakimura et al., 2015; Kusaba
et al., 2016; Wang W. et al., 2016): the von Frey hair sensitivity
test and the toe spread factor, both as compared to the healthy
limb and expressed as a percentage. The mean von Frey hair
sensitivity value was 13.8% and the toe spread factor ratio was
46.3%, consistent with the values for autografts measured in other
studies (Wang et al., 2012; Wakimura et al., 2015; Kusaba et al.,
2016; Wang W. et al., 2016), indicating comparable functional
recovery for AP-TS grafts and autografts at week 20.
Vascularization and Inflammation
Nerve grafts obtained with decellularization protocols often
proved inadequate for clinical application, and this inadequacy
was noted to increase linearly with graft length (He et al., 2012,
2014; Hayashida et al., 2015). A chief reason is that, ischemia,
degeneration, and necrosis can occur in the non-vascularized
parts of long, decellularized nerve grafts, associated with
slow regeneration and risk of graft failure (Hayashida et al.,
2015; Rbia and Shin, 2017). In conventional approaches with
autografts or isografts, revascularization is simpler and more
direct, based on reconnection with the existing vasculature
(Best et al., 1999). Differently, the native cells in decellularized
grafts, including endothelial cells, are removed, thus impeding
adequate and rapid support to the decellularized nerve scaffold.
Given the importance of this issue, and in order to better
understand the process of vascularization in decellularized
grafts, we analyzed two studies. Zhu et al. (2017) evaluated
patterns of microangiogenesis in decellularized grafts, while
Farber et al. (2016) completed the study by Saheb-Al-Zamani
et al. (2013) investigating the difference in vascularization
between long auto/isografts and decellularized grafts. Zhu
et al. (2017) studied short grafts (10 mm in length) and
demonstrated that nutrient supply relies on fluid permeation
from the surrounding tissues during the early stages after
the graft procedure. Microvessels started to grow at the graft
extremities and then penetrated into the decellularized nerve
matrix along the long axis. Moreover, they calculated that
the microvessels grew more rapidly in the autografts than
in the decellularized nerves. After 14 days, newly formed
microvessels were anastomosed at the midgraft in the autografts
AG, whereas the decellularized grafts needed 21 days for this
process.
Farber et al. (2016) demonstrated that long nerve grafts
(60 mm) need different times for complete vascularization,
depending on the approach used. Auto/isografts take about
5 days before the first signs of vascularization in the midgraft
appear, whereas decellularized nerves need about 20 days, as
shown in Zhu et al.’s (2017) study. The longer time to obtain
adequate vascularization might be the cause of cell damage and
senescence, oxidative stress, and other numerous pathological
processes. Hence, one of the main reasons why better outcomes
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are achieved with auto/isografts is this faster and higher
microvascularization capability of autografts. Angiogenesis and
the formation of new vascularization within the nerve graft are
two processes necessary for successful nerve regeneration and
must be taken into account in the development of functional
nerve grafts.
Another fundamental issue in decellularization is graft
biocompatibility, i.e., the risk of eliciting an inflammatory
response or immunological rejection of the transplanted nerve
matrix. During the decellularization process, a great quantity
of cells, myelin sheath, and ECM debris is generated, which
is theoretically able to activate inflammatory and macrophage
response that could damage the basement membrane and thus
delay regeneration (Gao et al., 2014b). Moreover, some of
these fragments might result immunogenic and able to activate
lymphocyte T cells, promoting their migration within the graft
and leading to its destruction. Therefore, it is important to
consider the pro-inflammatory and immunologic potential of
decellularized nerves used as a graft. In the present review,
six studies described immunological response to decellualarized
grafts (Jia et al., 2011; Godinho et al., 2013; Fan et al., 2014;
Jiang et al., 2015; Wakimura et al., 2015; Poppler et al., 2016;
Wang W. et al., 2016; Cai et al., 2017; Kaizawa et al., 2017). All
six studies used immunostaining to detect T lymphocyte (CD3,
CD4, CD8) and macrophage (CD68) activity. The majority of
the studies showed a slight increase in these cells as compared
with autografts within and in the immediate proximity of the
graft, especially during the first days after grafting, though
there was no statistical difference between these values. Only
Cai et al. (2017) reported a significant difference between
autografts and decellularized nerve grafts. Jiang et al. (2015)
quantified the serum concentration of inflammatory cytokines
(IL-2, TNF-α, and IFN-γ) after a grafting procedure but found
no significant increase in inflammatory cytokines in animals
grafted with a decellularized nerve graft and those that received
an autograft. These outcomes indicated no apparent graft
rejection during the early recovery period but only a restrained
inflammatory response. This means that decellularized nerves
are not subject to the cytotoxic effect of T lymphocytes and
macrophage degradation, making them fairly safe for in vivo
use.
CONCLUSION
With this literature review, we wanted to quantitatively analyze
the effectiveness of decellularized nerve grafts as possible
substitutes for auto/isografts, which currently represent the
current gold standard procedure in the treatment of severe nerve
injury. We evaluated functional and morphological parameters
that reflect the progressive recovery of nerve function. The
parameters were selected because they are the ones most
commonly used in the studies and the most representative
of the regeneration process. Among these parameters, muscle
functionality and histomorphometric analysis (axon diameter
and myelin sheath thickness) best predicted effective recovery
of nerve function. Restoration of muscle weight and tension
entails effective crossing of the nerve gap to reach the target
muscle. The histomorphometric evaluations not only highlighted
the graft’s morphological features but also its functional and
electrophysiological characteristics. Overall, histomorphometric
evaluations are subject to methodological sampling errors,
which may induce bias in the interpretation of the results.
We noted, for example, that myelin sheath thickness was
frequently overrated, supporting the hypothesis of common
errors in the evaluation of histomorphometric parameters, as
pointed out in our previously studies (Geuna et al., 2004; Geuna
and Herrera-Rincon, 2015). In contrast, SFI evaluation and
electrophysiological measurements are useful in the assessment
of nerve regeneration, though they, too, may be subject to error
and high variability (Monte-Raso et al., 2008; Geuna et al., 2009;
Fricker et al., 2016).
The main limitation of the present study was the lack of data
for numerous investigations: not all parameters were evaluated
for all decellularization protocols at all time points. Moreover,
only one evaluation reported by a single study was available
in many cases, making complete and exhaustive comparison
between the protocols not always possible.
Overall, although reported in only one study (Cai et al.,
2017), the most promising outcomes were obtained with the
grafts produced with the AP-TPA protocol. This protocol had
the best data for muscle wet weight ratio, myelinated fiber
number, axon diameter, and myelin sheath thickness, with all
values comparable to those of autografts evaluated at 8 weeks
after surgery. Moreover, the effectiveness of this protocol was
notable also for the length of the graft (15 mm, longer than
the critical size) and the time needed for decellularization
(the quickest among the in-house protocols and similar to
that of SP). Based on the promising results of AP-TPA,
further investigations should be carried out to confirm these
outcomes.
Among the well-established protocols, NP, especially when
performed after HP, seemed to be the most effective. In fact, it
resulted in grafts with sufficient muscle weight and tension ratio,
axon diameter, myelin sheath thickness, myelinated fiber number,
CV, and SFI (until week 9). Given that the NP grafts were the
longest on average (21 mm), the outcomes appeared even more
remarkable. This protocol is, in fact, used in the manufacture
of Avance R© processed nerve grafts (AxoGen, Inc., Alachua, FL,
United States), which is a decellularized nerve graft currently
employed in clinical practice. The protocol was developed with
the idea to improve on the effectiveness of the previously
developed, well-established protocols (SP and HP) by removing
chondroitin sulfate proteoglycans, which were demonstrated to
inhibit axonal growth (Krekoski et al., 2001; Jiang et al., 2016);
this improvement was confirmed in our analysis. The HP and the
SP showed similar results; however, based on specific parameters,
mainly muscle functionality, outcomes with the HP grafts were
slightly superior. This observation was confirmed by Nagao
et al. (2011) who compared SP, HP, and FTP grafts in the
same experimental procedure and reported a significantly better
improvement in SFI with use of HP grafts as compared to those
obtained with the other two protocols. Moreover, HP takes less
time to complete than SP. This can be explained by the fact
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that SP was the first decellularization protocol to be developed,
while HP is a later improvement with better preservation of
the ECM structure and an easier detergent removal step using
lower doses of chemicals (Hudson et al., 2004; Rieder et al., 2004;
Alhamdani et al., 2010; Serghei et al., 2010; Crapo et al., 2011).
Evaluation of FTP grafts was scarce, since it was evaluated only by
two studies (Nagao et al., 2011; Godinho et al., 2013) that reported
the lowest values for SFI, statistically lower than the HP grafts
(Nagao et al., 2011). Moreover, in the same experimental design,
the myelinated fiber density was lower in the FTP than in the
NP grafts (Godinho et al., 2013). Three major advantages of FTP
are that it is the quickest decellularization protocol, it requires
no chemicals, and the effect of decellularization is uniform on the
entire tissue, without depending on diffusion or perfusion (Crapo
et al., 2011). Nonetheless, the protocol has many limitations,
which explains the worse outcomes obtained. First the technique
causes rapid tissue expansion and contraction that can damage
basal lamina continuity, making axonal regeneration difficult.
Moreover, FTP kills cells in the tissue. Since it does not have a
washing step, the debris is not eliminated (Gulati and Cole, 1994;
Sondell et al., 1998; Szynkaruk et al., 2013), which might activate
inflammatory or immunological response (Gao et al., 2014b).
Concerning the other in-house protocols, the AP-T protocol
employed a longer time for decellularization and the outcomes
were generally slightly worse than with HP, particularly for
morphology. Finally, the AP-W protocol ranked last; its long
duration (2 weeks) makes it less attractive and effective than the
other protocols.
Table 7 summarizes the advantages and disadvantages of
the different techniques used to decellularize nerve grafts for
potential clinical use.
In conclusion, decellularized nerve grafts are a promising,
alternative to auto/isografts for the treatment of nerve injury,
even in the repair of defects with large gaps. They are
immunologically safe and some more than others support the
functional and morphological recovery of the injured nerve.
Although the use of peracetic acid showed very promising
outcomes, it needs to be further analyzed. The use of
chondroitinase ABC, introduced with NP, seems to effectively
improve the outcomes obtained with SP and HP. The use of
triton-X alone or in association with SDS did not seem to improve
the outcomes with the HP or the SP grafts. The worst results
were obtained with physical techniques (freeze/thaw or Wallerian
degeneration protocol); therefore, chemicals and washing steps
TABLE 7 | Advantages and disadvantages of the various protocols to decellularize nerve grafts.
Decellularization protocol Advantages Disadvantages
Sondell (SP) • SFI similar to autograft
• CV similar to autograft
• Motor endplates seriously atrophied and low recovery of
muscle functionality
• Very few regenerated myelinated nerve fibers
Hudson (HP) • Low percentage of chemical detergents
• Good muscle wet weight ratio at 10–15 weeks
• Axon diameter and myelinated sheath thickness
comparable to autografts at 10–15 weeks
• Low CV values 10–15 weeks after repair
Neubauer (NP) • Satisfying SFI
• Satisfying muscle weight and tension ratio
• Satisfying quantitative histomorphological
parameters (myelinated fiber number, axon diameter,
myelin sheath thickness)
• CV values halved of that registered in autografts
• Low myelinated fiber density
Freeze-and-thaw (FTP) • Quickest and less laborious protocol, no chemicals
are needed
• Low values of SFI
• Low myelinated fiber density
• Cell debris are not eliminated
• Damaged basal lamina and difficult axonal regeneration
Triton-X (AP-T) • Remarkable electrophysiological outcome
(considering the higher average graft length)
• Muscle tension ratio recovery similar to autografts
• Long time to the decellularization process
• Low values of SFI recovery
Triton-X + SDS (AP-TS) • Good progress in nerve regeneration (large axons at
25 weeks)
• Basal lamina preserved
• Few data comparable to the other protocols
Triton-X + peracetic acid (AP-TPA) • Quickest protocol between in-house protocols
• Muscle mass recovery (muscle wet weight ratio) at
8 weeks similar to autografts
• Quantitative histomorphological parameters
(myelinated fiber number, axon diameter, myelin
sheath thickness) at 8 weeks comparable with those
of the autograft at 10–15 weeks
• Only one paper describing this protocol
Wallerian degeneration (AP-W) • Myelin thickness of regenerating fibers similar to
autografts
• Longest protocol
• Muscle wet weight ratio recovery half than autografts
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are needed to obtain an effective decellularized nerve graft.
Finally, in order to further improve process performance,
a recellularization step could be introduced to produce a
graft that is able to substitute the current gold standard of
auto/isografts.
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